News Chart PharmaTher Holdings Ltd.

Equities

PHRM

CA71716H1082

Market Closed - Canadian Securities Exchange Other stock markets 03:22:58 2024-05-17 pm EDT			5-day change	1st Jan Change
0.215 ^CAD	0.00%		-10.42%	-31.75%

May. 15	PharmaTher's Sairiyo Submits Clinical Trial Application in Australia For Phase 1 Study of Reformulated Cepharanthine	MT
May. 10	PharmaTher Assigned FDA Approval Goal Date for its New Drug Application for Ketamine	MT

501df4b38c7418cfcbc068e3.N5777mTHlaEVlE5fnRaL6-tj6vvSs5M1FHHKQMr_3uk.TtKDtAOw1-dg3hss6TvCsqoOm8Ln_L5mIx6-NanJkIZfycOmI4v04G3WOQ~af2a214f75e49e5bed512833b637c162